These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 214688)

  • 1. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.
    Scriba M
    Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent genital Herpes simplex virus (HSV) infection of guinea pigs.
    Scriba M
    Med Microbiol Immunol; 1976 Dec; 162(3-4):201-8. PubMed ID: 187918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus.
    Skinner GR; Williams DR; Moles AW; Sargent A
    Arch Virol; 1980; 64(4):329-38. PubMed ID: 6249243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: factors influencing efficacy.
    Stanberry LR; Myers MG; Stephanopoulos DE; Burke RL
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3177-85. PubMed ID: 2558156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.
    Bernstein DI; Ashley RL; Stanberry LR; Myers MG
    J Clin Microbiol; 1990 Jan; 28(1):11-5. PubMed ID: 2153698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for control of herpes simplex virus disease through immunization.
    Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
    Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
    Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
    J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal studies on the efficacy of vaccination against recurrent herpes.
    Scriba M
    Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
    Bernstein DI; Miller RL; Harrison CJ
    J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.
    Sturn B; Schneweis KE
    Med Microbiol Immunol; 1978 Jul; 165(2):119-27. PubMed ID: 209295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC; Collins DJ; Marciani DJ; Kern ER
    Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
    Maragos C; Miller A; May JT
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in herpes simplex virus immunobiology and vaccine research.
    Koelle DM; Corey L
    Clin Microbiol Rev; 2003 Jan; 16(1):96-113. PubMed ID: 12525427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal delivery of herpes simplex virus vaccine.
    Bowen JC; Alpar HO; Phillpotts R; Brown MR
    Res Virol; 1992; 143(4):269-78. PubMed ID: 1329168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
    Berman PW; Gregory T; Crase D; Lasky LA
    Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.